Current situation and prospect of extrapolation of overseas clinical trial data in ChinaJIA Guo-shu, WANG Min-hui, LIANG Yi969-976
Advances in generic drug approval process and challenges in the U.S. after Hatch-Waxman ActPENG Yun-peng, XU Yi-hua977-984
An empirical study on influencing factors of cooperative innovation capital investment in different sub-sectors of China's pharmaceutical manufacturing industryFAN Ming-jie, QU Feng-hong985-988
Key technologies and evidence evaluation elements for retrieval of ancient documents of "traditional Chinese medicine theory" under the triple-combination systemYANG Jing, REN Xing, LV Xing, LI Jing-hua, GAO Rui989-993
Pacritinib:a new Janus activated kinase 2/Fms-like tyrosine kinase 3 inhibitor for the treatment of myelofibrosisWANG Yong-yi, HUANG Lu, JI Xue-mei994-999
Bioactivity determination of human insulin using in-cell WesternWANG Lv-yin, YANG Yan-feng, LIANG Yu-ling, ZHANG Hui, LI Jing, LIANG Cheng-gang1000-1006
International development of vaccine platform technology and its implications for China's strategic stockpile of emerging infectious diseasesMA Ji-yan, LIU Zuo-kun, HUANG Yang-mu1007-1012
The role of dual specificity tyrosine-phosphorylation-regulated kinase 1A in the pathogenesis of Alzheimer's diseaseJV Cheng, ZANG Cai-xia, BAO Xiu-qi, ZHANG Dan1013-1020
Advances in the establishment and application of preclinical tumor modelsXU Han-lin, CHEN Jian-jun, ZHAO Fei, CHANG Yan, LI Ying-qi, LI Man-qi, HE Wei-wei1021-1027
Progress in research on the anti-inflammatory effect of curcumin on chronic inflammatory diseasesWANG Xin-li, DONG Wei, XU Xi-qiang, LI Qiu-xiang, ZHOU Ai-xian, LIANG Xin-li1028-1036